SCREENING FOR THE IMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE AUTOMATIC DEFIBRILLATOR

NACompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

January 5, 2022

Study Completion Date

February 14, 2023

Conditions
Sudden Cardiac DeathImplantable Defibrillator
Interventions
PROCEDURE

new screening procedure with small variations in electrode positioning

"Every ICD patient will undergo the standard screening process. Initial screening will be performed as usually performed by physician or Boston Scientific technical support. In case of one or more vector satisfying screening criteria, patient will be assigned in screening success group. In case of failure, a pre-determined electrode positioning protocol will be done with variation of para-sternal and axillary electrodes. Positioning variations will be left to the discretion of the operator cardiologist."

Trial Locations (16)

Unknown

CHRU de BREST, Brest

CHU de Caen, Caen

CHRU de Lille, Lille

Hopital Saint Philivert, Lille

CHU de Limoges, Limoges

Hopitl Cardiologique Louis Pradel, Lyon

CHU de Nancy, Nancy

CHU de Nantes, Nantes

AP-HP Hôpital européen Georges-Pompidou, Paris

APHP - Pitié Salpêtrière, Paris

CH de Pau, Pau

CHU de Rennes, Rennes

CHRU de Strasbourg, Strasbourg

CHU deToulouse, Toulouse

Clinique Pasteur, Toulouse

CHU de Tours, Tours

All Listed Sponsors
lead

Centre Hospitalier de PAU

OTHER

NCT04101253 - SCREENING FOR THE IMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE AUTOMATIC DEFIBRILLATOR | Biotech Hunter | Biotech Hunter